NextCell Pharma AB
STO:NXTCL
NextCell Pharma AB
Other Items
NextCell Pharma AB
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NextCell Pharma AB
STO:NXTCL
|
Other Items
-kr55k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Other Items
kr256k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Other Items
-kr685k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Other Items
-kr32m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-200%
|
CAGR 10-Years
-14%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Other Items
-kr1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Other Items
-kr894.7m
|
CAGR 3-Years
-3 647%
|
CAGR 5-Years
-606%
|
CAGR 10-Years
N/A
|
|
NextCell Pharma AB
Glance View
NextCell Pharma AB engages in the development of stem cell products. The company is headquartered in Huddinge, Stockholm. The company went IPO on 2017-07-13. The firm is focusing on research and development of stem cell therapies and is also running a tissue establishment and biobank, classified as healthcare provider. NextCell's business concept is to develop and commercialize mesenchymal stem cell products based on the Company's proprietary selection algorithm, primarily for the treatment of autoimmune diabetes, as well as other types of autoimmune diseases.
See Also
What is NextCell Pharma AB's Other Items?
Other Items
-55k
SEK
Based on the financial report for Aug 31, 2025, NextCell Pharma AB's Other Items amounts to -55k SEK.
What is NextCell Pharma AB's Other Items growth rate?
Other Items CAGR 1Y
-9 067%
Over the last year, the Other Items growth was -9 067%.
